International Journal of Pharmaceutical Compounding

A subscription to IJPC includes a print copy delivered by postal mail and on-line access to electronic PDF copies of your subscribed issues.

LEARN MORE

Ursodiol 30 mg/mL in SyrSpend SF Cherry Oral Suspension

Author(s): Allen Loyd V Jr

Issue: Nov/Dec 2019 - Volume 23, Number 6
View All Articles in Issue

Page(s): 493

Ursodiol 30 mg/mL in SyrSpend SF Cherry Oral Suspension Page 1

Download in electronic PDF format for $65

Abstract: A formulation for preparing Ursodiol 30 mg/mL in SyrSpend SF Cherry Oral Suspension. Includes ingredients, method of preparation, discussion, and references for the compounding pharmacist.

Related Keywords: Loyd V. Allen, Jr., PhD, RPh, ursodiol, formulation, ursodeoxycholic acid, secondary biliary acid, gallstones, primary biliary cholangitis, primary biliary cirrhosis, cholelithiasis

Related Categories: EXCIPIENTS, FORMULATIONS, GASTROENTEROLOGY, UROLOGY/URINARY TRACT

Printer-Friendly Version

Title/Author (Click for Abstract / Details / Purchase)	Issue/Page View/Buy
Related Articles from IJPC
Ursodiol 30 mg/mL in SyrSpend SF Cherry Oral Suspension Allen Loyd V Jr	Nov/Dec 2019 Pg. 493
Stability of Ursodiol in SyrSpend SF Cherry Flavored Geiger Christine M, Voudrie Mark A II, Sorenson Bridget	Nov/Dec 2012 Pg. 510-512
Ursodiol 100 mg/mL in Cod Liver Oil, Veterinary Allen Loyd V Jr	May/Jun 2020 Pg. 232
Rapid-Dissolve Technology: An Interview With Loyd V. Allen, Jr., PhD, RPh Allen Loyd V Jr	Nov/Dec 2003 Pg. 449-450
Ursodiol 50-mg/mL Oral Suspension Allen Loyd V Jr	Sep/Oct 2011 Pg. 427
Basics of Compounding for Cough Allen Loyd V Jr	Nov/Dec 2004 Pg. 462-465
Compounding in the Pharmacy Curriculum: Beyond the Basics Hinkle Amanda R, Newton Gail D	May/Jun 2004 Pg. 181-185
Acidifying Agents, Featured Excipient: Allen Loyd V Jr	Jul/Aug 1999 Pg. 309-310
Stability of Compounded Ursodiol Suspensions in PCCA Base, SuspendIt Pramar Yashoda V, Mandal Tarun K, Bostanian Levon A, Nguyen Anh TQ, Miller Valicia, Morris Tommy C, Graves Richard A	Jan/Feb 2019 Pg. 70-76
Ursodiol 25-mg/mL Oral Liquid Allen Loyd V Jr	Nov/Dec 2005 Pg. 480
Penicillamine-D 50 mg/mL in SyrSpend SF pH4 Oral Suspension Allen Loyd V Jr	Jan/Feb 2018 Pg. 55
Compatibility of Baclofen, Carvedilol, Hydrochlorothiazide, Mercaptopurine, Methadone Hydrochloride, Oseltamivir Phosphate, Phenobarbital, Propranolol Hydrochloride, Pyrazinamide, Sotalol Hydrochloride, Spironolactone, Tacrolimus Monohydrate, Ursodeoxycholic Acid, and Vancomycin Hydrochloride Oral Suspensions Compounded with SyrSpend SF pH4 Polonini Hudson, da Silva Sharlene Loures, Brandão Marcos Antônio Fernandes, Bauters Tiene, De Moerloose Barbara, Ferreira Anderson de Oliveira	Nov/Dec 2018 Pg. 516-526
Trichloroacetic Acid 20%, Salicylic Acid 20%, Lactic Acid 10% in Flexible Collodion Allen Loyd V Jr	Sep/Oct 2015 Pg. 410
Midazolam 1 mg/mL in SyrSpend SF or SyrSpend SF Cherry Allen Loyd V Jr	Jul/Aug 2018 Pg. 321
Nifedipine 4.mg/mL in SyrSpend SF pH4 Cherry Flavored Allen Loyd V Jr	Jul/Aug 2021 Pg. 327
Phenobarbital 10 mg/mL in SyrSpend SF pH4, Cherry Flavored Allen Loyd V Jr	Mar/Apr 2022 Pg. 146
A Need for Propylene Glycol-Free Ascorbic Acid Oral Liquid McElhiney Linda F	Nov/Dec 2004 Pg. 458-460
Dapsone 2 mg/mL in SyrSpend SF pH4 Oral Suspension Allen Loyd V Jr	Nov/Dec 2017 Pg. 491
Alprazolam 1 mg/mL in SyrSpend SF pH4 Oral Suspension Allen Loyd V Jr	Mar/Apr 2022 Pg. 140
Atropine Sulfate 0.1 mg/mL in SyrSpend SF pH4 Oral Suspension Allen Loyd V Jr	Sep/Oct 2021 Pg. 412